Sanofi launches dedicated vaccines mRNA Center of Excellence
- Details
- Category: Sanofi
![Sanofi Sanofi](/images/logo/sanofi.png)
Roche's Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children
- Details
- Category: Roche
![Roche Roche](/images/logo/roche.png)
Novartis and Hewlett Packard Enterprise join forces to advance Novartis global health efforts
- Details
- Category: Novartis
![Novartis Novartis](/images/logo/novartis.png)
BioNTech announces first patient dosed in Phase 2 clinical trial of mRNA-based BNT111 in patients with advanced melanoma
- Details
- Category: Business
![BioNTech BioNTech](/images/logo/biontech.png)
GSK and Vir Biotechnology announce continuing progress of the COMET clinical development programme for sotrovimab
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/logo/gsk.png)
AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/logo/astrazeneca.png)
CureVac provides update on Phase 2b/3 trial of first-generation COVID-19 vaccine candidate, CVnCoV
- Details
- Category: Business
![CureVac CureVac](/images/logo/curevac.png)
More Pharma News ...
- U.S. government purchases additional 200 million doses of Moderna's COVID-19 vaccine
- Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease in PREVENT-19 Phase 3 trial
- Pfizer and BioNTech to provide 500 million doses of COVID-19 vaccine to U.S. government for donation to poorest nations
- Valneva completes Phase 3 trial recruitment for its inactivated COVID-19 vaccine candidate
- Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson's disease
- Pfizer and BioNTech receive first authorization in European Union for COVID-19 vaccine in adolescents
- Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19